Currency In USD
| Previous Close | 19.54 |
| Open | 19.1 |
| Day High | 19.12 |
| Day Low | 17.86 |
| 52-Week High | 37.5 |
| 52-Week Low | 16.24 |
| Volume | 3.08M |
| Average Volume | 2.18M |
| Market Cap | 3.48B |
| PE | -27.69 |
| EPS | -0.68 |
| Moving Average 50 Days | 19.72 |
| Moving Average 200 Days | 22.19 |
| Change | -0.71 |
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
GlobeNewswire Inc.
Feb 24, 2026 1:00 PM GMT
SOMERSET, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 10, 2026, to review fourth-quar
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 12, 2026 1:00 PM GMT
Exceeded 10,000 patients treated to date with CARVYKTI® (ciltacabtagene autoleucel; cilta-cel)Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy manufacturing facility in the U
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 17, 2025 1:00 PM GMT
SOMERSET, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will present the latest co